Celvestrant PFS Injection
Marketer
Celon Laboratories Ltd
Salt Composition
Fulvestrant (250mg)
Overview Celvestrant PFS Injection
Casodex injection is a medication that blocks estrogen's effects. Postmenopausal women with breast cancer receive this treatment. Its mechanism involves regulating estrogen levels to curb cancer cell proliferation. Administered intramuscularly under medical guidance, the dosage and frequency depend on individual needs and the physician's assessment of symptom management. Treatment duration follows the doctor's prescription. Common side effects include injection site reactions, headache, nausea, vomiting, and allergic responses. Report any concerning symptoms to your doctor, who may suggest mitigating strategies. Before initiating treatment, inform your doctor of any history of kidney or liver disease, bleeding disorders, anticoagulant use, or other medications you're taking, as interactions may affect efficacy. Disclose any pregnancy, pregnancy plans, or breastfeeding.
Uses of Celvestrant PFS Injection
Malignant breast tumor
Major Benefits of Celvestrant PFS Injection:
This medication will be administered by your physician or their designated nurse. Self-medication is strongly discouraged.
Common Side effects of Celvestrant PFS Injection:
- Headache
- Vomiting
- Weakness
- Allergic reaction
- Nausea
- Injection site reaction
- Urinary tract infection
- Diarrhea
How to use Celvestrant PFS Injection:
This medication will be administered by your healthcare provider; self-medication is strongly discouraged.
How Celvestrant PFS Injection works:
Celvestrant PFS Injection inhibits estrogen's activity within breast cancer cells, potentially halting or reducing the growth of estrogen-dependent tumors.
SAFETY ADVICE
AlcoholCAUTION
Use of alcohol with Celvestrant PFS Injection necessitates careful consideration. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
Administering Celvestrant PFS Injection during pregnancy is contraindicated due to established fetal risks. In exceptional, life-threatening circumstances, a physician may consider its use if the potential benefits outweigh the known hazards. Physician consultation is mandatory.
Breast feedingUNSAFE
Using Celvestrant PFS Injection while breastfeeding is contraindicated due to potential infant toxicity. Evidence indicates the drug may harm the nursing infant.
DrivingSAFE
Driving ability is typically unaffected by Celvestrant PFS Injection.
KidneyCAUTION
Celvestrant PFS Injection requires careful administration in individuals with severe renal impairment, potentially necessitating dosage modification. Consult your physician for guidance. Data on Celvestrant PFS Injection use in such patients is limited. Dosage alteration is not advised for those with mild or moderate kidney disease.
LiverCAUTION
Patients with liver impairment should receive Celvestrant PFS Injection cautiously, as dose modification may be necessary. Physician consultation is advised.
What if you forget to take Celvestrant PFS Injection :
Should you forget a scheduled Celvestrant PFS Injection, seek your physician's advice.
Facts to Know About Celvestrant PFS Injection
| Label | Value |
|---|---|
| Chemical Type | Estrogen Derivatives |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Behavioral Class | Estrogen receptor blocker |
3,018 People bought this recently